Abstract:Background: Evidence suggests that the beneficial effects of weight-loss diet interventions on improvement in cardiovascular risk factors may be partly through modulating secretion of adiponectin from adipose tissue. However, it remains unclear whether the long-term weight-loss diets change adiponectin levels; and how such changes, if exist, affect cardiometabolic risk. Objectives: To investigate effects of weight-loss diets with different compositions of macronutrients on long-term changes of circulating adiponectin concentrations and cardiometabolic risk factors, as well as dietary interactions with variation in the adiponectin gene. Methods: In the 2-year Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial, 811 overweight or obese adults were randomly assigned to 1 of 4 diets; the targeted percentages of energy derived from fat, protein, and carbohydrates in the 4 diets were 20, 15, and 65%; 20, 25, and 55%; 40, 15, and 45%; and 40, 25, and 35%. The current analysis was restricted to participants who had baseline plasma adiponectin measurement (n=768). Circulating adiponectin and cardiometabolic outcomes were repeatedly measured at baseline, 6 months, and 2 years. We genotyped single-nucleotide polymorphism rs266171 in the adiponectin gene. Linear mixed models were used to compare changes in adiponectin concentrations across diet groups over the intervention and predict trajectory of changes in cardiometabolic risk factors. Results: Circulating adiponectin concentrations significantly increased over 2 years, similarly in 4 weight-loss diet intervention groups. Change of plasma adiponectin was significantly associated with decreases in weight, waist circumference, triglycerides, fasting insulin, and insulin resistance measured by homeostasis model assessment of insulin resistance (HOMA-IR), and increase in HDL cholesterol, after adjusting for age, gender, ethnicity, follow-up time, diet group, and baseline level of respective outcome trait. The associations remained similar after further controlling for concurrent weight change. In addition, we observed significant interactions between rs266717 genotype and dietary fat on changes in fasting insulin and HOMA-IR (P for interaction=0.03 for both) at 6 months with adjustment for covariates. Participants who are homozygous for T allele of rs266717 had more reductions in fasting insulin and HOMA-IR than those with other genotypes in response to the high-fat diet, but such differences were not observed in the low-fat diet group. Conclusions: Regardless of macronutrient compositions, weight-loss diets beneficially increased circulating adiponectin, which was related to improvement of cardiometabolic profiles. Dietary fat intakes modified the effect of adiponectin variant rs266717 on improvement of insulin resistance.

Genetic, Epigenetic and Transcriptional Variations at NFATC2IP Locus with Weight Loss in Response to Diet Interventions: the POUNDS Lost Trial.

Abstract 15398: Genetic, Epigenetic, and Transcriptional Variations at NFATC2IP Locus With Weight Loss in Response to Diet Interventions: The POUNDS Lost Trial

DNA Methylation at ABCG1 and Long-term Changes in Adiposity and Fat Distribution in Response to Dietary Interventions: The POUNDS Lost Trial

DNA Methylation of Birthweight–Blood Pressure Genes and Changes of Blood Pressure in Response to Weight-Loss Diets in the POUNDS Lost Trial

HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: the POUNDS Lost and DIRECT trials.

DNA Methylation Near CPT1A and Changes in Triglyceride-rich Lipoproteins in Response to Weight-loss Diet Interventions

Abstract 11956: Blood DNA Methylation Predicts Differential Metabolic Outcomes Induced by Different Types of Weight-Loss Intervention: Findings From an Epigenome-Wide Association Study

Genetic Determinant For Amino Acid Metabolites And Changes In Body Weight And Insulin Resistance In Response To Weight-Loss Diets The Preventing Overweight Using Novel Dietary Strategies (Pounds Lost) Trial

Abstract 47: Weight-loss Diets, Adiponectin, and Changes of Cardiometabolic Risk in the 2-Year Pounds Lost Trial

Gene–Diet Interaction on Body Weight Maintenance

Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk

Genetically Determined Gut Microbiome Abundance and 2-Year Changes in Central Adiposity and Body Composition: the POUNDS Lost Trial

IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial.

Abstract MP18: DNA Methylation Variants, B Vitamins Intake, and Long-Term Weight Change: Gene-Diet Interactions in Two Us Cohorts

Macronutrient Intake–Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: the POUNDS Lost Trial

Genetic Variations Of Circulating Adiponectin Levels Modulate Changes In Appetite In Response To Weight-Loss Diets

DNA methylation is differentially associated with glycemic outcomes by different types of weight-loss interventions: an epigenome-wide association study

Vitamin D Metabolism-Related Genetic Variants, Dietary Protein Intake and Improvement of Insulin Resistance in a 2 Year Weight-Loss Trial: POUNDS Lost

DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial

Distinct genetic subtypes of adiposity and glycemic changes in response to weight-loss diet intervention: the POUNDS Lost trial

Subcutaneous adipose tissue gene expression and DNA methylation respond to both short- and long-term weight loss